Bishop Score vs. Cervical Length in Labor Induction
Bishop Score Versus Cervical Length by Transvaginal Ultrasound for Predicting Success of Labor Induction Among Primigravida
1 other identifier
observational
88
0 countries
N/A
Brief Summary
The study population consists of term primigravida women undergoing induction of labor at a tertiary care referral center in Assiut, Egypt.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Sep 2026
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 28, 2025
CompletedFirst Posted
Study publicly available on registry
October 6, 2025
CompletedStudy Start
First participant enrolled
September 1, 2026
ExpectedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2027
Study Completion
Last participant's last visit for all outcomes
November 30, 2027
October 6, 2025
September 1, 2025
10 months
September 28, 2025
September 28, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Rate of vaginal delivery
The proportion of women achieving vaginal delivery after induction of labor within 24 hours of initiation.
Within 24 hours
Study Arms (2)
Transvaginal Ultrasound Group (TVUS):
Participants undergo sonographic measurement of cervical length. A CL \<28 mm is considered favorable for successful induction. This method provides an objective and reproducible cervical assessment.
Bishop Score Group (BS):
Participants undergo digital vaginal examination to assign Bishop Scores. A score ≥6 is considered favorable for induction. This is the traditional method of assessing cervical readiness.
Eligibility Criteria
Participants include 88 primigravida women at ≥37 weeks of gestation, each with a singleton pregnancy in cephalic presentation. All participants present with medical or obstetric indications for induction of labor, such as post-dates, oligohydramnios, mild preeclampsia, or premature rupture of membranes. Exclusion criteria include prior uterine surgery, multiple pregnancies, malpresentation, placenta previa, vasa previa, non-reassuring fetal status at admission, or maternal infections such as active genital herpes and HIV. A carefully designed sample size calculation ensures adequate power, with a final cohort of 44 women per study arm.
You may qualify if:
- Singleton pregnancy
- Cephalic fetal presentation
- Gestational age ≥37 weeks (confirmed by reliable dating)
- Indication for induction of labor (postdate pregnancy, oligohydramnios, mild preeclampsia, premature rupture of membranes)
You may not qualify if:
- Previous uterine surgery (e.g., cesarean section, myomectomy)
- Multiple gestation
- Malpresentation
- Placenta previa or vasa previa
- Non-reassuring fetal heart status at admission
- Active genital herpes or HIV infection
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- resident at the Obstetrics and Gynecology department
Study Record Dates
First Submitted
September 28, 2025
First Posted
October 6, 2025
Study Start (Estimated)
September 1, 2026
Primary Completion (Estimated)
June 30, 2027
Study Completion (Estimated)
November 30, 2027
Last Updated
October 6, 2025
Record last verified: 2025-09